201 related articles for article (PubMed ID: 24864249)
1. Endocannabinoid receptors gene expression in morbidly obese women with nonalcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Terra X; Martinez S; Aguilar C; Filiu E; Alibalic A; Sabench F; Hernández M; Del Castillo D; Richart C
Biomed Res Int; 2014; 2014():502542. PubMed ID: 24864249
[TBL] [Abstract][Full Text] [Related]
2. Altered fatty acid metabolism-related gene expression in liver from morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Berlanga A; Guiu-Jurado E; Martinez S; Porras JA; Aragonès G; Sabench F; Hernandez M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2014 Dec; 15(12):22173-87. PubMed ID: 25474087
[TBL] [Abstract][Full Text] [Related]
3. PNPLA3 Expression Is Related to Liver Steatosis in Morbidly Obese Women with Non-Alcoholic Fatty Liver Disease.
Aragonès G; Auguet T; Armengol S; Berlanga A; Guiu-Jurado E; Aguilar C; Martínez S; Sabench F; Porras JA; Ruiz MD; Hernández M; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27128907
[TBL] [Abstract][Full Text] [Related]
4. Plasma visfatin levels and gene expression in morbidly obese women with associated fatty liver disease.
Auguet T; Terra X; Porras JA; Orellana-Gavaldà JM; Martinez S; Aguilar C; Lucas A; Pellitero S; Hernández M; Del Castillo D; Richart C
Clin Biochem; 2013 Feb; 46(3):202-8. PubMed ID: 23174488
[TBL] [Abstract][Full Text] [Related]
5. Increased Hepatic
Barrientos-Riosalido A; Real M; Bertran L; Aguilar C; Martínez S; Parada D; Vives M; Sabench F; Riesco D; Castillo DD; Richart C; Auguet T
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674839
[TBL] [Abstract][Full Text] [Related]
6. The Potential Protective Role of RUNX1 in Nonalcoholic Fatty Liver Disease.
Bertran L; Pastor A; Portillo-Carrasquer M; Binetti J; Aguilar C; Martínez S; Vives M; Sabench F; Porras JA; Riesco D; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34063472
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoid receptor CB2 in nonalcoholic fatty liver disease.
Mendez-Sanchez N; Zamora-Valdes D; Pichardo-Bahena R; Barredo-Prieto B; Ponciano-Rodriguez G; Bermejo-Martínez L; Chavez-Tapia NC; Baptista-González HA; Uribe M
Liver Int; 2007 Mar; 27(2):215-9. PubMed ID: 17311616
[TBL] [Abstract][Full Text] [Related]
8. Liver lipocalin 2 expression in severely obese women with non alcoholic fatty liver disease.
Auguet T; Terra X; Quintero Y; Martínez S; Manresa N; Porras JA; Aguilar C; Orellana-Gavaldà JM; Hernández M; Sabench F; Lucas A; Pellitero S; Del Castillo D; Richart C
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):119-24. PubMed ID: 23426707
[TBL] [Abstract][Full Text] [Related]
9. Role of cannabinoid receptors in alcoholic hepatic injury: steatosis and fibrogenesis are increased in CB2 receptor-deficient mice and decreased in CB1 receptor knockouts.
Trebicka J; Racz I; Siegmund SV; Cara E; Granzow M; Schierwagen R; Klein S; Wojtalla A; Hennenberg M; Huss S; Fischer HP; Heller J; Zimmer A; Sauerbruch T
Liver Int; 2011 Jul; 31(6):860-70. PubMed ID: 21645218
[TBL] [Abstract][Full Text] [Related]
10. Hepatic expression of endocannabinoid receptors and their novel polymorphisms in primary biliary cirrhosis.
Floreani A; Lazzari R; Macchi V; Porzionato A; Variola A; Colavito D; Leon A; Guido M; Baldo V; De Caro R; Bergasa NV
J Gastroenterol; 2010; 45(1):68-76. PubMed ID: 19730968
[TBL] [Abstract][Full Text] [Related]
11. Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis.
Auguet T; Bertran L; Binetti J; Aguilar C; Martínez S; Sabench F; Lopez-Dupla JM; Porras JA; Riesco D; Del Castillo D; Richart C
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32545403
[TBL] [Abstract][Full Text] [Related]
12. Deregulation of Secreted Frizzled-Related Protein 5 in Nonalcoholic Fatty Liver Disease Associated with Obesity.
Bertran L; Portillo-Carrasquer M; Aguilar C; Porras JA; Riesco D; Martínez S; Vives M; Sabench F; Gonzalez E; Del Castillo D; Richart C; Auguet T
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34198988
[TBL] [Abstract][Full Text] [Related]
13. miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease.
Auguet T; Aragonès G; Berlanga A; Guiu-Jurado E; Martí A; Martínez S; Sabench F; Hernández M; Aguilar C; Sirvent JJ; Del Castillo D; Richart C
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669236
[TBL] [Abstract][Full Text] [Related]
14. Hepcidin in morbidly obese women with non-alcoholic fatty liver disease.
Auguet T; Aragonès G; Berlanga A; Martínez S; Sabench F; Binetti J; Aguilar C; Porras JA; Molina A; Del Castillo D; Richart C
PLoS One; 2017; 12(10):e0187065. PubMed ID: 29065180
[TBL] [Abstract][Full Text] [Related]
15. Retinol binding protein-4 circulating levels were higher in nonalcoholic fatty liver disease vs. histologically normal liver from morbidly obese women.
Terra X; Auguet T; Broch M; Sabench F; Hernández M; Pastor RM; Quesada IM; Luna A; Aguilar C; del Castillo D; Richart C
Obesity (Silver Spring); 2013 Jan; 21(1):170-7. PubMed ID: 23505183
[TBL] [Abstract][Full Text] [Related]
16. PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis.
Francque S; Verrijken A; Caron S; Prawitt J; Paumelle R; Derudas B; Lefebvre P; Taskinen MR; Van Hul W; Mertens I; Hubens G; Van Marck E; Michielsen P; Van Gaal L; Staels B
J Hepatol; 2015 Jul; 63(1):164-73. PubMed ID: 25703085
[TBL] [Abstract][Full Text] [Related]
17. Expression of energy metabolism related genes in the gastric tissue of obese individuals with non-alcoholic fatty liver disease.
Mehta R; Birerdinc A; Wang L; Younoszai Z; Moazzez A; Elariny H; Goodman Z; Chandhoke V; Baranova A; Younossi ZM
BMC Gastroenterol; 2014 Apr; 14():72. PubMed ID: 24716593
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic fatty liver disease.
Rossi F; Bellini G; Alisi A; Alterio A; Maione S; Perrone L; Locatelli F; Miraglia del Giudice E; Nobili V
PLoS One; 2012; 7(8):e42259. PubMed ID: 22927922
[TBL] [Abstract][Full Text] [Related]
20. Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.
Wei Y; Wang X; Wang L
Mol Vis; 2009 Jun; 15():1243-51. PubMed ID: 19547718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
